Literature DB >> 23628504

Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds.

Jerome Boursier, John F Rawls, Anna Mae Diehl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23628504     DOI： 10.1016/j.cgh.2013.04.016

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  3 in total

Review 1.  Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis.

Authors:  Weifeng Zhu; Ying Zhou; Rong Tsao; Huanhuan Dong; Hua Zhang
Journal:  Front Nutr       Date:  2022-05-17

Review 2.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 3.  The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.

Authors:  Yun Ji; Yue Yin; Lijun Sun; Weizhen Zhang
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.